NCT05906511
PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 10 versions: 10 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 20 words Show 4 more changesShow less
- Trial completed
- Study completion date changed from estimate of Aug 31, 2026 to Apr 13, 2026
- Site details revised
- Publications: details revised at 7 of 8 entries
- Minor Primary completion moved earlier from Jun 30, 2026 to Apr 13, 2026v9
- Minor Site contact updatedv8
- Notable Primary completion date: Aug 31, 2025 to Jun 30, 2026
- Study completion date: Aug 31, 2025 to Aug 31, 2026
- Study description shortened, about 5 words
- Notable Enrollment target: 30 to 20
- Primary and study completion dates: Apr 30, 2025 to Aug 31, 2025
- Study description expanded, about 1 word
Show 4 earlier versionsHide 4 earlier versions
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study completion date: Jul 30, 2025 to Apr 30, 2025
- Start date changed from estimate of Dec 1, 2023 to Oct 17, 2023
- Site details revised
- Notable Start date: Oct 15, 2023 to Dec 1, 2023
- Collaborators: 1 to 2
- Notable Enrollment target: 20 to 30
- Start date: Sep 15, 2023 to Oct 15, 2023
- Eligibility criteria expanded, about 133 words
- Study description expanded, about 78 words
- Minor Primary completion date: Aug 2025 to Apr 30, 2025
- Study completion date: Oct 2025 to Jul 30, 2025
- Start date: Aug 2023 to Sep 15, 2023
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Peak concentration (Cmax)
Timeframe: Up to 8 hours
Time to attain Cmax concentration (Tmax)
Timeframe: Up to 8 hours
Area under the plasma concentration-time curve (AUC0-8h)
Timeframe: Up to 8 hours
Nociception
Timeframe: Up to 8 hours
Abuse Liability
Timeframe: Up to 8 hours
Arms and interventions
Dronabinol 5mgActive comparator
Dronabinol 5 mg
Dronabinol 10mgPlacebo comparator
Dronabinol 10 mg
Vaporized THC 2mgActive comparator
Vaporized THC 2mg
Vaporized THC 4mgActive comparator
Vaporized THC 4 mg
PlaceboPlacebo comparator
Masked oral placebo or vaporized saline
Drugs: Dronabinol 5 MG, Dronabinol 10 MG, 2mg Purified THC in an ethanolic solution, 4mg Purified THC in an ethanolic solution, Placebo
Sites
1 site in 1 country
- VA Connecticut Healthcare SystemWest Haven, Connecticut, United States